Jagsonpal Pharmaceuticals Limited (BOM:507789)
India · Delayed Price · Currency is INR 210.55
+0.65 (0.31%)
At close: Nov 14, 2025
Jagsonpal Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 2,827 | 2,687 | 2,087 | 2,367 | 2,176 | 1,879 | Upgrade |
| 2,827 | 2,687 | 2,087 | 2,367 | 2,176 | 1,879 | Upgrade | |
Revenue Growth (YoY) | 24.60% | 28.76% | -11.83% | 8.79% | 15.77% | 18.53% | Upgrade |
Cost of Revenue | 1,029 | 969.61 | 805.48 | 926.98 | 896.91 | 812.37 | Upgrade |
Gross Profit | 1,797 | 1,718 | 1,282 | 1,440 | 1,279 | 1,067 | Upgrade |
Selling, General & Admin | 849.04 | 820.97 | 635.52 | 729.76 | 703.71 | 658.72 | Upgrade |
Other Operating Expenses | 342.68 | 317.83 | 272.55 | 269.53 | 319.67 | 209.64 | Upgrade |
Operating Expenses | 1,340 | 1,288 | 1,065 | 1,101 | 1,039 | 879.22 | Upgrade |
Operating Income | 457.38 | 429.4 | 216.07 | 338.85 | 239.87 | 187.86 | Upgrade |
Interest Expense | -9.33 | -8.58 | -7.77 | -2.78 | -2.61 | -4.28 | Upgrade |
Interest & Investment Income | 76.45 | 76.45 | 85.92 | 34.28 | 15.46 | 29.92 | Upgrade |
Other Non Operating Income (Expenses) | 31.99 | 4.45 | 4.47 | 3.11 | 1.5 | 5.21 | Upgrade |
EBT Excluding Unusual Items | 556.49 | 501.72 | 298.69 | 373.46 | 254.22 | 218.72 | Upgrade |
Merger & Restructuring Charges | -34.97 | -34.97 | - | - | - | - | Upgrade |
Impairment of Goodwill | - | - | - | -0.3 | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | 5.92 | 11.35 | - | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 3.59 | 0.85 | - | Upgrade |
Asset Writedown | -1.75 | -1.75 | - | -27.79 | - | - | Upgrade |
Other Unusual Items | 266.44 | 233.59 | - | -6.8 | - | - | Upgrade |
Pretax Income | 786.21 | 698.59 | 298.69 | 348.08 | 266.42 | 218.72 | Upgrade |
Income Tax Expense | 166.79 | 144.98 | 74.06 | 80.87 | 77.87 | 48.14 | Upgrade |
Net Income | 619.42 | 553.61 | 224.63 | 267.21 | 188.55 | 170.58 | Upgrade |
Net Income to Common | 619.42 | 553.61 | 224.63 | 267.21 | 188.55 | 170.58 | Upgrade |
Net Income Growth | 154.91% | 146.45% | -15.93% | 41.72% | 10.53% | 116.73% | Upgrade |
Shares Outstanding (Basic) | 67 | 67 | 66 | 65 | 65 | 65 | Upgrade |
Shares Outstanding (Diluted) | 67 | 67 | 66 | 65 | 65 | 65 | Upgrade |
Shares Change (YoY) | 0.41% | 1.56% | 1.23% | - | - | - | Upgrade |
EPS (Basic) | 9.21 | 8.26 | 3.40 | 4.08 | 2.88 | 2.60 | Upgrade |
EPS (Diluted) | 9.18 | 8.22 | 3.39 | 4.08 | 2.88 | 2.60 | Upgrade |
EPS Growth | 153.81% | 142.48% | -16.91% | 41.72% | 10.55% | 117.00% | Upgrade |
Free Cash Flow | 400.69 | 549.52 | 349.18 | 463.37 | 58.65 | 277.53 | Upgrade |
Free Cash Flow Per Share | 5.94 | 8.16 | 5.27 | 7.08 | 0.90 | 4.24 | Upgrade |
Dividend Per Share | - | 2.500 | 2.000 | 2.000 | 1.600 | 0.400 | Upgrade |
Dividend Growth | - | 25.00% | - | 25.00% | 300.00% | 100.00% | Upgrade |
Gross Margin | 63.59% | 63.92% | 61.41% | 60.84% | 58.78% | 56.78% | Upgrade |
Operating Margin | 16.18% | 15.98% | 10.35% | 14.31% | 11.02% | 10.00% | Upgrade |
Profit Margin | 21.91% | 20.60% | 10.76% | 11.29% | 8.67% | 9.08% | Upgrade |
Free Cash Flow Margin | 14.18% | 20.45% | 16.73% | 19.57% | 2.70% | 14.77% | Upgrade |
EBITDA | 537.55 | 496.31 | 221.13 | 347.11 | 255.13 | 198.72 | Upgrade |
EBITDA Margin | 19.02% | 18.47% | 10.60% | 14.66% | 11.73% | 10.57% | Upgrade |
D&A For EBITDA | 80.17 | 66.91 | 5.06 | 8.26 | 15.26 | 10.86 | Upgrade |
EBIT | 457.38 | 429.4 | 216.07 | 338.85 | 239.87 | 187.86 | Upgrade |
EBIT Margin | 16.18% | 15.98% | 10.35% | 14.31% | 11.02% | 10.00% | Upgrade |
Effective Tax Rate | 21.21% | 20.75% | 24.80% | 23.23% | 29.23% | 22.01% | Upgrade |
Revenue as Reported | 2,936 | 2,769 | 2,180 | 2,424 | 2,210 | 1,923 | Upgrade |
Advertising Expenses | - | 175.42 | 138.58 | 147.3 | 102.19 | 96.22 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.